Company news

Halozyme Therapeutics, Inc. news in 2019

Halozyme Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Data From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Halozyme's ENHANZE® Drug Delivery Technology To Be Presented At San Antonio Breast Cancer Symposium

December 11, 2019

Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $400 Million of Convertible Senior Notes due 2024

November 12, 2019

Halozyme Therapeutics, Inc. Announces Proposed Offering of $400 Million of Convertible Senior Notes due 2024

November 11, 2019

Halozyme Reports Third Quarter 2019 Results

November 11, 2019

Halozyme Announces HALO-301 Phase 3 Study Fails To Meet Primary Endpoint

November 3, 2019

Halozyme Announces Actions To Focus Strategy On ENHANZE® Drug Delivery Technology

November 3, 2019

Halozyme To Host Third Quarter 2019 Financial Results Webcast And Conference Call

October 20, 2019

Halozyme To Participate In 2019 Cantor Global Healthcare Conference

September 22, 2019

Halozyme Reports Second Quarter 2019 Results

August 5, 2019

Halozyme To Host Second Quarter 2019 Financial Results Webcast And Conference Call

July 22, 2019

Halozyme Announces Janssen Submits Extension Application To European Medicines Agency For Subcutaneous Formulation Of DARZALEX® Utilizing ENHANZE® Technology

July 18, 2019

Halozyme Announces First Clinical Dosing In argenx's Phase 1 Trial Of Efgartigimod (ARGX-113) With ENHANZE® Drug Delivery Technology

July 16, 2019

Halozyme Announces Janssen Submits BLA To FDA For Subcutaneous Formulation Of DARZALEX® Utilizing ENHANZE® Technology

July 11, 2019

Halozyme Announces CRADA With National Institute of Allergy and Infectious Diseases For Use Of ENHANZE® Drug Delivery Technology

June 24, 2019

Halozyme Announces argenx Has Selected Second Target Under ENHANZE® Technology Collaboration And License Agreement

May 21, 2019

Halozyme To Host First Quarter 2019 Financial Results Webcast And Conference Call

April 22, 2019

Decks in 2019